August 27, 2008

Gilead Sciences to Present at the Thomas Weisel Partners Healthcare Conference on Wednesday, September 3

Webcast Available Through Gilead Corporate Website

John C. Martin, PhD, Gilead's Chairman and Chief Executive Officer, will provide an overview of the company on Wednesday, September 3 at 10:55 a.m. Eastern Time.

To access the live webcast via the internet log on to www.gilead.com. Please connect to the company's website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary to listen to the webcast.

About Gilead

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

For more information on Gilead Sciences, please visit www.gilead.com or call the Gilead Public Affairs Department at 1-800-GILEAD-5 (1-800-445-3235).

SOURCE: Gilead Sciences, Inc.

Gilead Sciences, Inc. Patrick O'Brien, Investor Relations, 650-522-1936

Investors

Jacquie Ross
investors_relations@gilead.com

Media Contact

Meaghan Smith
public_affairs@gilead.com

Other News

Some of the content on this page is not intended for users outside the U.S.